Vaginal Discharge Described Like "Skittles"
Immediate Diagnostic Approach
The term "Skittles" discharge typically refers to a rainbow-colored or multicolored vaginal discharge, which is most commonly associated with bacterial vaginosis (BV) when the discharge appears grayish-white with a characteristic fishy odor, though the exact color description requires clinical correlation with pH testing and microscopy to differentiate between BV, candidiasis, and trichomoniasis. 1, 2
Essential Bedside Tests
Perform these three simple tests immediately to establish diagnosis:
Measure vaginal pH using narrow-range pH paper applied directly to vaginal secretions—pH >4.5 indicates BV or trichomoniasis, while pH ≤4.5 suggests candidiasis 1, 2, 3
Perform whiff test by adding 10% KOH to vaginal discharge—a fishy amine odor confirms BV or trichomoniasis 4, 1, 3
Examine wet mount microscopy with saline preparation to identify motile trichomonads (trichomoniasis) or clue cells (BV), and KOH preparation to identify yeast or pseudohyphae (candidiasis) 4, 2
Differential Diagnosis Based on Clinical Findings
Bacterial Vaginosis (Most Likely)
- Appearance: Homogeneous, thin, white-gray discharge coating vaginal walls 4, 3
- Odor: Fishy smell, especially after intercourse or with KOH application 4, 5
- pH: >4.5 1, 2
- Microscopy: Clue cells (>20% of epithelial cells with bacteria attached to borders) 4, 5
- Diagnosis requires: 3 of 4 Amsel criteria present 5, 4
Vulvovaginal Candidiasis
- Appearance: Thick, white "cottage cheese" or "curdled" discharge 3, 5
- Symptoms: Intense vulvar itching, burning, vulvar erythema and edema 1, 5
- pH: Normal range 3.8-4.5 1, 5
- Microscopy: Hyphae or budding yeast visible in 50-70% of cases 4, 5
Trichomoniasis
- Appearance: Yellow-green, frothy, profuse discharge 1, 6
- Odor: Foul-smelling 5, 6
- pH: >4.5 (present in 70% of cases) 5
- Microscopy: Motile trichomonads on wet mount (detected in only 50-75% of cases) 4, 5
- Cervical findings: Red punctate lesions ("strawberry cervix") in some cases 4
Treatment Protocols
For Bacterial Vaginosis
First-line treatment is metronidazole 500 mg orally twice daily for 7 days, which achieves a 95% cure rate and is superior to single-dose regimens. 2, 3
- Alternative regimen: Clindamycin cream intravaginally 2
- Critical patient instruction: Avoid all alcohol during treatment and for 24 hours after completion to prevent disulfiram-like reactions 3
- Complete the full 7-day course even if symptoms resolve early to reduce recurrence risk 3
For Vulvovaginal Candidiasis
- Standard treatment: Fluconazole 150 mg orally as a single dose (55% therapeutic cure rate) 1, 2
- Alternative: Intravaginal agents such as clotrimazole, miconazole, terconazole, butoconazole, or tioconazole 1
- For recurrent infections: Fluconazole 150 mg weekly for 6 months to maintain clinical and mycologic control 2, 5
For Trichomoniasis
- Standard treatment: Metronidazole 2 grams orally as a single dose (90-95% cure rate) 2, 6
- Essential: Treat sexual partners simultaneously to prevent reinfection 1, 2, 3
- Treatment failure is usually due to non-treatment of the male partner 5
Critical Pitfalls to Avoid
Never treat based on symptoms alone—always confirm diagnosis with pH and microscopy, as wet mount can miss trichomoniasis 30-50% of the time 4, 3
Do not use metronidazole as a single 2-gram dose for BV—it requires a 7-day course for optimal cure rates, unlike trichomoniasis 3
Do not treat male partners for BV or candidiasis—only trichomoniasis requires partner treatment, as partner treatment does not reduce BV recurrence rates 2, 3
Avoid douching—it alters normal vaginal flora and increases risk of BV 1
Do not treat asymptomatic Candida colonization—approximately 10-20% of women have Candida in the vagina without symptoms and do not require treatment 1
When to Reconsider the Diagnosis
If symptoms persist after treatment, reconsider trichomoniasis even with negative initial wet mount, as microscopy misses it 30-50% of the time 4
If laboratory testing fails to identify a cause, consider mixed infections, as a substantial minority of women may have concurrent infections 3
For persistent or recurrent symptoms within 2 months, consider treatment failure, reinfection, or alternative diagnoses such as desquamative inflammatory vaginitis, genitourinary syndrome of menopause, or vulvodynia 7
Follow-Up Recommendations
No routine follow-up needed if symptoms completely resolve after treatment 2, 3
Return for evaluation if symptoms persist or recur within 2 months, which may indicate treatment failure or reinfection requiring extended therapy or alternative agents 2, 3
Recurrence of BV is common (50-80% within one year) but does not change initial management 2, 8